TRCT
DWTX

Tower Research Capital (TRC)’s Dogwood Therapeutics DWTX Stock Holding History

Tower Research Capital (TRC)’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17K Buy
+8,067
New +$23.7K ﹤0.01% 3594
2025
Q4 		– Sell
-744
Closed -$5.73K – 5719
2025
Q3 		$5.73K Sell
744
-48
-6% -$239 ﹤0.01% 4206
2025
Q2 		$3.78K Sell
792
-258
-25% -$1.25K ﹤0.01% 4436
2025
Q1 		$5.26K Buy
1,050
+78
+8% +$528 ﹤0.01% 4138
2024
Q4 		$2.42K Buy
972
+699
+256% +$2.31K ﹤0.01% 4845
2024
Q3 		$1.16K Sell
273
-2
-0.7% -$10 ﹤0.01% 5197
2024
Q2 		$1.48K Buy
275
+3
+1% +$26 ﹤0.01% 5153
2024
Q1 		$3.26K Buy
272
+4
+1% +$45 ﹤0.01% 4895
2023
Q4 		$3.85K Sell
268
-83
-24% -$1.4K ﹤0.01% 5035
2023
Q3 		$8.11K Buy
351
+260
+286% +$9.04K ﹤0.01% 4390
2023
Q2 		$3.15K Buy
+91
New +$2.6K ﹤0.01% 5101
2022
Q3 		– Sell
-59
Closed -$6K – 6571
2022
Q2 		$6K Sell
59
-46
-44% -$4.81K ﹤0.01% 4969
2022
Q1 		$12K Buy
105
+104
+10,400% +$15.1K ﹤0.01% 4109
2021
Q4 		$0 Sell
1
-95
-99% -$12.1K ﹤0.01% 6649
2021
Q3 		$13K Buy
96
+35
+57% +$4.84K ﹤0.01% 4108
2021
Q2 		$10K Buy
61
+33
+118% +$4.68K ﹤0.01% 4407
2021
Q1 		$4K Buy
+28
New +$4.87K ﹤0.01% 4817

Other funds holding DWTX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tower Research Capital (TRC)'s DWTX Position: Q1 2026 in Review

Tower Research Capital (TRC) opened a new position in Dogwood Therapeutics (DWTX) in Q1 2026: 8,067 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #3594 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in DWTX as recently as Q3 2025.

Tower Research Capital (TRC) first reported a position in DWTX in Q1 2021 and has held it in 17 quarters since. 13 funds tracked by Wall St. Rank hold DWTX as of Q1 2026.

  • Tower Research Capital (TRC) held 8,067 shares of Dogwood Therapeutics worth $17K as of Q1 2026.
  • Dogwood Therapeutics was a new Tower Research Capital (TRC) position in Q1 2026.
  • Dogwood Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3594 holding.
  • Tower Research Capital (TRC) first reported a position in Dogwood Therapeutics in Q1 2021 and has held it in 17 quarters since.
  • 13 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.